Investing.com - Financial Markets Worldwide

Paragon 28 Inc (FNA)

NYSE
Currency in USD
13.09
0.00(0.00%)
Real-time Data·
Showing Paragon 28 historical data. For real-time data please try another search
Day's Range
13.0713.11
52 wk Range
4.6513.13
Key Statistics
Edit
Prev. Close
13.09
Open
13.09
Day's Range
13.07-13.11
52 wk Range
4.65-13.13
Volume
-
Average Volume (3m)
2.53M
1-Year Change
60.22%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Paragon 28 Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Paragon 28 Inc Company Profile

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. The company offers forefoot systems, including gorilla precision MTP plating system, gorilla precision lapidus plating system, phantom lapidus intramedullary nail system, Bun-Yo-Matic lapidus clamp, and precision MIS screw system; and fracture fixation systems comprising gorilla ankle fracture plating system, baby gorilla plating system, monster screw system, monkey bars external fixation system, R3Flex syndesmotic repair system, and phantom fibula nail system. It also provides flatfoot systems, such as gorilla universal plating system, JAWS great white staple system, monster screw system, grappler suture anchor system, and mister tendon harvester system; ankle replacement system consists of metallic and plastic implant components, as well as ankle fusion plating system and phantom hindfoot nailing system; Charcot systems, including the joust beaming system, gorilla medial column plating system, and monkey rings external fixation system; and orthobiologics products, such as V92 cellular bone matrix, PRESERVE bone wedges, MgNum bone void filler, and BEAST demineralized bone matrix. The company serves hospitals, ambulatory surgery centers, and health care facilities through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado. As of April 21, 2025, Paragon 28, Inc. operates as a subsidiary of Zimmer Biomet Holdings, Inc.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
525
Market
United States

Paragon 28 Inc SWOT Analysis

Niche Market Leade
Paragon 28 dominates the foot and ankle orthopedic device market, leveraging its specialized focus to outpace larger competitors in this growing segment
Financial Milestones
Explore Paragon 28's journey to profitability, marked by its first EBITDA-positive quarter and strong revenue growth, especially in international markets
Analyst Optimism
With price targets ranging from $15 to $20, analysts express confidence in Paragon 28's growth potential and market positioning
Strategic Efficiency
Delve into Paragon 28's operational improvements, including key leadership appointments and workforce optimization, aimed at accelerating profitability
Read full SWOT analysis

Paragon 28 Inc Earnings Call Summary for Q3/2024

  • Record Q3 revenue of $62.3M, up 18.1% YoY; U.S. revenue up 14.8%, international up 35.7%
  • First positive adjusted EBITDA since IPO at $432K; free cash flow usage down 69.5% YoY to $6.3M
  • Full-year 2024 revenue guidance raised to $252M-$256M; targeting EBITDA positivity in 2025
  • 13 new products launched, including Phantom Fibula Nail System; $8M annualized OpEx savings expected
  • Focus on inventory reduction; sales team productivity up 4%; SMART 28 module driving forefoot procedure growth
Last Updated: 14/11/2024, 10:22
Read Full Transcript

Earnings

Latest Release
Jul 30, 2025
EPS / Forecast
-- / -0.12
Revenue / Forecast
-- / 69.61M
EPS Revisions
a
a
Unlock
Last 90 days

FNA Income Statement

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.